Madeline Li

Madeline Li, MD, PhD

Dr. Madeline Li is a clinician-scientist in the Department of Supportive Care, Princess Margaret Cancer Centre. She completed a MD/PhD degree, with graduate studies in molecular genetics from the Department of Medical Biophysics, Ontario Cancer Institute, followed by a psychiatry residency at the University of Toronto and a fellowship in psychiatric oncology and psychoneuroimmunology at the Princess Margaret Cancer Centre.
In addition to clinical practice in cancer psychiatry, Dr. Li conducts multi-disciplinary research in the areas of psychoneuroimmunology, genetics and psychosocial oncology. She is developing a research program exploring the biological contributions to psychological distress in cancer patients. This includes establishing connections between basic laboratory sciences and psychosocial research departments and advocacy to de-stigmatize and promote psycho-education about psychiatric illness in medical illness.
 
Current research projects involve characterization of cytokine profiles and genetic vulnerability as contributors to depression in cancer patients, and studies exploring the roles of psychological, endocrine, immunologic, and nervous system biomarkers as mediators of non-specific cancer symptoms and symptom clusters, such as pain, depression, fatigue, and insomnia.
 
Her psychosocial research includes educational strategies on clinical management of depression and anxiety in cancer patients, in addition to screening for emotional distress. She is the developer and physician lead of the Distress Assessment and Response Tool (DART) program at the Princess Margaret, and a co-lead on the Improving Patient Experience and Health Outcomes Collaborative with Cancer Care Ontario.
 
BMC Nephrol. 2017 Dec 06;18(1):356
Wong D, Cao S, Ford H, Richardson C, Belenko D, Tang E, Ugenti L, Warsmann E, Sissons A, Kulandaivelu Y, Edwards N, Novak M, Li M, Mucsi I
Eur J Cancer Care (Engl). 2017 Oct 06;:
McCusker J, Yaffe M, Faria R, Lambert S, Li M, Poirier-Bisson J, Magalhaes M, de Raad M
N Engl J Med. 2017 08 31;377(9):897-8
Li M, Rodin G
Bipolar Disord. 2017 May;19(3):198-213
Soczynska JK, Kennedy SH, Alsuwaidan M, Mansur RB, Li M, McAndrews MP, Brietzke E, Woldeyohannes HO, Taylor VH, McIntyre RS
N Engl J Med. 2017 May 25;376(21):2082-2088
Li M, Watt S, Escaf M, Gardam M, Heesters A, O'Leary G, Rodin G
Psychooncology. 2016 Nov 15;:
Li M, Kouzmina E, McCusker M, Rodin D, Boutros PC, Paige CJ, Rodin G
Psychooncology. 2016 Sep 19;
Li M, Kennedy EB, Byrne N, Gérin-Lajoie C, Katz MR, Keshavarz H, Sellick S, Green E
J Oncol Pract. 2016 Jul 5;
Li M, Kennedy EB, Byrne N, Gérin-Lajoie C, Katz MR, Keshavarz H, Sellick S, Green E
J Oncol Pract. 2016 Apr 5;
Li M, Macedo A, Crawford S, Bagha S, Leung Y, Zimmermann C, Fitzgerald B, Wyatt M, Stuart-McEwan T, Rodin G, Li M, Macedo A, Crawford S, Bagha S, Leung Y, Zimmermann C, Fitzgerald B, Wyatt M, Stuart-McEwan T, Rodin G
BMJ Support Palliat Care. 2016 Jan 19;
Lo C, Hales S, Chiu A, Panday T, Malfitano C, Jung J, Rydall A, Li M, Nissim R, Zimmermann C, Rodin G

Pages


Assistant Professor, Department of Psychiatry, University of Toronto
Scientist, Behavioural Sciences and Health Research, University Health Network
Committee Member, Psychosocial Oncology Program, Cancer Care Ontario